Parmax Pharma Ltd.
Search Company
Income Statement  You can view the Income statement for the last 5 years.
ISIN No INE240T01014 52Wk High (Rs.) 55 BV (Rs.) -7.21 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 28 EPS (Rs.) 0.00 P/E (X) 0.00
Mkt Cap. (Rs. Cr.) 13.28 P/BV (X) -4.92 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]28.2011.0515.4218.2526.20
Total Operating Revenues28.2011.0515.4218.2526.20
      
Other Income0.040.050.040.060.09
Total Revenue28.2411.1015.4618.3126.29
      
EXPENSES     
Cost Of Materials Consumed21.547.035.516.7213.41
Operating And Direct Expenses2.203.143.343.824.01
Changes In Inventories Of FG,WIP And Stock-In Trade0.000.02-0.02-0.010.02
Employee Benefit Expenses2.992.912.803.463.54
Finance Costs0.590.620.370.390.35
Depreciation And Amortisation Expenses1.031.711.881.931.94
Other Expenses1.221.321.531.701.81
Total Expenses29.5716.7615.4218.0125.08
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-1.32-5.660.050.301.21
      
Exceptional Items-1.070.000.000.000.00
Profit/Loss Before Tax-2.40-5.660.050.301.21
      
Tax Expenses-Continued Operations     
Current Tax0.000.000.190.230.28
Deferred Tax-0.300.00-0.04-0.050.16
Tax For Earlier Years0.000.120.00-0.010.01
Total Tax Expenses-0.300.120.150.160.45
Profit/Loss After Tax And Before ExtraOrdinary Items-2.09-5.78-0.100.140.75
      
Profit/Loss From Continuing Operations-2.09-5.78-0.100.140.75
      
Profit/Loss For The Period-2.09-5.78-0.100.140.75
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-5.60-11.33-0.280.382.02
Diluted EPS (Rs.)-5.60-11.33-0.280.382.02